Varian's Q1 Revenues Slip in Advance of Agilent Merger Completion
February 08, 2010
Varian's Q1 Revenues Slip in Advance of Agilent Merger Completion
Varian's Q1 revenues dipped 3 percent due to lower sales volume and lower average selling prices of certain analytical instruments products, the firm said.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.